E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Continued research toward the development of new antifungals that act via inhibition of glycosylphosphatidylinositol (GPI) biosynthesis led to the design of E1210. In this study, we assessed the selectivity of the inhibitory activity of E1210 against Candida albicans GWT1 (Orf19.6884) protein, Aspergillus fumigatus GWT1 (AFUA_1G14870) protein, and human PIG-W protein, which can catalyze the inositol acylation of GPI early in the GPI biosynthesis pathway, and then we assessed the effects of E1210 on key C. albicans virulence factors. E1210 inhibited the inositol acylation activity of C. albicans Gwt1p and A. fumigatus Gwt1p with 50% inhibitory concentrations (IC 50 s) of 0.3 to 0.6 μM but had no inhibitory activity against human Pig-Wp even at concentrations as high as 100 μM. To confirm the inhibition of fungal GPI biosynthesis, expression of ALS1 protein, a GPI-anchored protein, on the surfaces of C. albicans cells treated with E1210 was studied and shown to be significantly lower than that on untreated cells. However, the ALS1 protein levels in the crude extract and the RHO1 protein levels on the cell surface were found to be almost the same. Furthermore, E1210 inhibited germ tube formation, adherence to polystyrene surfaces, and biofilm formation of C. albicans at concentrations above its MIC. These results suggested that E1210 selectively inhibited inositol acylation of fungus-specific GPI which would be catalyzed by Gwt1p, leading to the inhibition of GPI-anchored protein maturation, and also that E1210 suppressed the expression of some important virulence factors of C. albicans , through its GPI biosynthesis inhibition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prodrug is metabolized by phosphatases and converted to manogepix (APX001A, formerly E1210) which inhibits the Gwt1 but not the human homolog Pig-W (Watanabe et al., 2012; Wiederhold et al., 2019).”
From Fungal Cell Wall: Emerging Antifungals and Drug Resistance. (2019) · cites this paper as Watanabe et al., 2012
In the citing paper
“MGX inhibits the conserved fungal glycosylphosphatidylinositol (GPI)-anchored wall transfer protein 1 (Gwt1) (13, 14).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [14]
In the citing paper
“There is limited information on the activity of this new class of antifungals, but in an early study manogepix inhibited C. albicans adherence and biofilm formation in a concentration dependent manner among other virulence factors [47].”
From Antifungal therapy of Candida biofilms: Past, present and future (2023) · cites this paper as [47]
In the citing paper
“E1210 is a broad-spectrum antifungal agent with a novel mechanism of action based on the inhibition of fungal glycosylphosphatidylinositol biosynthesis [144, 145].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [144]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801 · cited 1×
“The incidence of life-threatening fungal infections has increased steadily over the past 2 decades as a result of an increase in the number of susceptible immunosuppressed patients (39, 68).”
BackgroundLee, K. L., Buckley, H. R., & Campbell, C. C. (1975) · Medical Mycology · doi:10.1080/00362177585190271 · Cited by 788 · cited 1×
“5% glucose (YNB), Spider medium (31), Lee’s medium (28), YPD broth (Becton Dickinson Company) supplemented with 10% fetal calf serum (FCS), and yeast nitrogen base without amino acids but supplemented with 2.”
MethodSuppression of Hyphal Formation in Candida albicans by Mutation of a STE12 Homolog
Liu, H., Köhler, J., & Fink, G. R. (1994) · Science · doi:10.1126/science.7992058 · Cited by 786 · cited 1×
“5% glucose (YNB), Spider medium (31), Lee’s medium (28), YPD broth (Becton Dickinson Company) supplemented with 10% fetal calf serum (FCS), and yeast nitrogen base without amino acids but supplemented with 2.”
MethodStandardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · cited 1×
“Resistance is also becoming an increasing problem, particularly among members of the azole class (33, 44, 45, 47, 66).”
BackgroundRamage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678 · cited 2×
“albicans have each been reported to be associated with biofilm formation (3, 41, 49).”
BackgroundMethodArchitecture of the Yeast Cell Wall
Kollár, R., Reinhold, B. B., Petráková, E., Yeh, H. J. C., Ashwell, G., Drgonová, J., Kapteyn, J. C., Klis, F. M., & Cabib, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17762 · Cited by 644 · cited 1×
“synthesis and assembly are GPI anchored, and GPI synthesis and/or anchoring is essential for cell viability in yeasts (27, 29, 43, 46).”
BackgroundThe ALS gene family of Candida albicans.
Hoyer, L. L. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)01984-9 · Cited by 540 · cited 1×
“Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55); Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb…”
Background
Research works printed but not linked: 3
- Clinical Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-third edition M27–A3. Clinical and Laboratory Standards Institute Wayne PA.
- SmithTK. 2009. Inhibitors of GPI biosynthesis, P. 247–267. In MenonAK KinoshitaT OrleanP TamanoiF (ed.), The enzymes, vol. XXVI. Glycosylphosphatidylinositol (GPI) anchoring of proteins, Academic Press, London, United Kingdom.
- Yoko-oT JigamiY. 2009. Inositol acylation/deacylation, p. 65–90. In MenonAK KinoshitaT OrleanP TamanoiF (ed.), The enzymes, vol. XXVI. Glycosylphosphatidylinositol (GPI) anchoring of proteins. Academic Press, London, United Kingdom.
Cited by
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467
“The action of manogepix appears to be fungal pathogen specific, as it does not inhibit human inositol acylation by the closest mammalian ortholog, PIGW [64, 72].”
BackgroundSpampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411
“E1210 is a broad-spectrum antifungal agent with a novel mechanism of action based on the inhibition of fungal glycosylphosphatidylinositol biosynthesis [144, 145].”
BackgroundKinoshita, T., & Fujita, M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r063313 · Cited by 273
“Importantly, the compound seems to be fungal specific and does not inhibit mammalian GPI inositol acylase PIG-W activity (194).”
Background
Metadata
- Authors
- Watanabe, N.-A., Miyazaki, M., Horii, T., Sagane, K., Tsukahara, K., & Hata, K.
- Affiliations
- Next Generation Systems Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Ibaraki, Japan
- Eisai (Japan) (JP)
- ORCID
- Sagane, Koji
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-02
- Volume
- 56
- Issue
- 2
- Pages
- 960-971
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3264227
- OpenAlex
- W1987354838
- Cited by
- 169
- References
- 67
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 20 · 2023: 14 · 2022: 14 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 12 · 2017: 14 · 2016: 6 · 2015: 6 · 2014: 7 · 2013: 5 · 2012: 2
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal agents, Candida albicans, Aspergillus fumigatus, glycosylphosphatidylinositol biosynthesis, virulence factors, germ tube formation, biofilm formation, ALS1, Rho1
- MeSH terms
- Acylation, Aminopyridines, Antifungal Agents, Candida albicans, Candidiasis, Fungal Proteins, Humans, Inositol, Isoxazoles, Virulence, Gene Expression Regulation, Fungal, Glycosylphosphatidylinositols, Hyphae, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis. https://app.cochat.ai/papers/10.1128/aac.00731-11
- The paper
- Watanabe, N.-A., Miyazaki, M., Horii, T., Sagane, K., Tsukahara, K., & Hata, K. (2012). E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00731-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.